全文获取类型
收费全文 | 1641篇 |
免费 | 182篇 |
国内免费 | 50篇 |
专业分类
耳鼻咽喉 | 13篇 |
儿科学 | 126篇 |
妇产科学 | 31篇 |
基础医学 | 169篇 |
口腔科学 | 91篇 |
临床医学 | 152篇 |
内科学 | 381篇 |
皮肤病学 | 33篇 |
神经病学 | 68篇 |
特种医学 | 205篇 |
外科学 | 170篇 |
综合类 | 118篇 |
预防医学 | 146篇 |
眼科学 | 10篇 |
药学 | 88篇 |
中国医学 | 4篇 |
肿瘤学 | 68篇 |
出版年
2023年 | 17篇 |
2022年 | 23篇 |
2021年 | 35篇 |
2020年 | 29篇 |
2019年 | 16篇 |
2018年 | 26篇 |
2017年 | 49篇 |
2016年 | 47篇 |
2015年 | 38篇 |
2014年 | 85篇 |
2013年 | 92篇 |
2012年 | 52篇 |
2011年 | 51篇 |
2010年 | 84篇 |
2009年 | 83篇 |
2008年 | 41篇 |
2007年 | 80篇 |
2006年 | 45篇 |
2005年 | 36篇 |
2004年 | 31篇 |
2003年 | 19篇 |
2002年 | 15篇 |
2001年 | 40篇 |
2000年 | 26篇 |
1999年 | 22篇 |
1998年 | 78篇 |
1997年 | 69篇 |
1996年 | 64篇 |
1995年 | 61篇 |
1994年 | 50篇 |
1993年 | 46篇 |
1992年 | 22篇 |
1991年 | 27篇 |
1990年 | 33篇 |
1989年 | 33篇 |
1988年 | 35篇 |
1987年 | 25篇 |
1986年 | 34篇 |
1985年 | 26篇 |
1984年 | 15篇 |
1983年 | 23篇 |
1982年 | 14篇 |
1981年 | 15篇 |
1980年 | 17篇 |
1979年 | 13篇 |
1978年 | 18篇 |
1977年 | 9篇 |
1976年 | 21篇 |
1975年 | 11篇 |
1971年 | 6篇 |
排序方式: 共有1873条查询结果,搜索用时 15 毫秒
1.
By injecting small amounts of CO2 through a needle, one can move bowel or bladder from the intended path of instruments during interventional procedures. The technique worked well in six of seven cases in the pelvis and retroperitoneum; it was not effective in the mediastinum or midabdomen (n = 6). 相似文献
2.
外科医生和手术室人员经常接触手术设备产生的烟气,病人也会暴露于烟气中,特别是腹腔镜手术中产生的烟气滞留于腹腔内这一密闭空间并被吸收.这些烟气是一种与香烟烟气相似的毒性物质,然而对这种毒性物质的影响还未引起足够重视.应该采取必要措施尽可能减少手术中烟气的不良影响. 相似文献
3.
4.
5.
6.
7.
8.
Calciphylaxis – a topical overview 总被引:3,自引:0,他引:3
G Arseculeratne† AT Evans‡ SM Morley† 《Journal of the European Academy of Dermatology and Venereology》2006,20(5):493-502
'Calciphylaxis', a calcification syndrome associated with ischaemic cutaneous necrosis, is acquired naturally in humans in disease states. It is a life and limb-threatening complication, usually observed in patients with renal disease and secondary hyperparathyroidism, but known to occur in the absence of renal or parathyroid disease. The reported mortality rate, which ranges from 60-80%, relates to wound infection, sepsis and organ failure. It is a small-vessel vasculopathy, which is estimated to occur in about 4% of haemodialysis patients. Clinically, violaceous, reticulate areas of cutaneous necrosis and eschar may be evident, particularly in the extremities. In addition to the clinical picture, a raised calcium phosphorous product, an elevated parathyroid hormone level, radiographic evidence of vessel and soft-tissue calcification and the finding of mural calcification affecting small arteries and arterioles on histopathology help to confirm the diagnosis of this entity which generally has a poor prognosis. A high index of suspicion and an active multidisciplinary management approach, with rigorous attention to wound care and prevention of sepsis, are vital in the management of these patients. In this overview, we discuss the pathophysiology, clinical features and associations, risk factors, diagnosis and management issues relating to calciphylaxis. 相似文献
9.
C M Paap M C Nahata M A Mentser J D Mahan S K Puri J A Hubbard 《The Annals of pharmacotherapy》1992,26(3):341-343
OBJECTIVE: To characterize the pharmacokinetics of cefotaxime and desacetylcefotaxime in pediatric patients undergoing continuous ambulatory peritoneal dialysis (CAPD) after intraperitoneal administration of cefotaxime. DESIGN: Case series. SETTING: Ambulatory children from Children's Hospital nephrology clinic, Columbus, Ohio. PATIENT POPULATION: Two adolescents without peritonitis. METHODS: A single intraperitoneal dose of cefotaxime 500 mg per 1 L dianeal was given during CAPD. Cefotaxime and desacetyl-cefotaxime were measured in plasma, urine, and dialysate by HPLC. RESULTS: Maximum plasma concentration (Cmax) of cefotaxime was 11.94 and 13.08 mg/L and that of desacetylcefotaxime 5.73 and 5.33 mg/L. Time to reach maximum concentration (Tmax) of cefotaxime was 2.22 and 4.08 h, and that of desacetylcefotaxime was 5.33 and 5.73 h after instillation of the intraperitoneal cefotaxime dose. Systemic absorption of cefotaxime was 56.6 and 64.8 percent. Total clearance of cefotaxime was 62 and 79 mL/min/1.73 m2. Nonrenal clearance accounted for nearly 95 percent; renal and CAPD clearance contributed approximately 5 percent of the total clearance. Renal and CAPD clearance measurements of desacetylcefotaxime were similar to those for cefotaxime. Cefotaxime half-life was 1.83 and 2.49 h and desacetylcefotaxime half-life was 8.14 and 11.0 h. CONCLUSIONS: Cefotaxime was well absorbed and therapeutic serum concentrations were achieved after intraperitoneal administration. Renal and CAPD clearances for cefotaxime and desacetylcefotaxime were low. Cefotaxime nonrenal clearance was unaffected. Further studies are needed to establish appropriate intraperitoneal dosing guidelines of cefotaxime in pediatric CAPD patients. 相似文献
10.
Summary The content of these papers has been heavily weighted towards reconstructions performed utilizing segments of stomach. This was not done to place a value judgment on this type of reconstruction, rather it helps establish an awareness of: (1) potentially serious metabolic and gastrointestinal complications not previously reported in children and (2) particularly frequent symptomatic disturbances collectively included in the hematuria-dysuria syndrome. Recognition of problems specifically associated with a certain type of intestinal segment, as well as complications generally accompanying any form of intestinal reconstruction, will hopefully provide pediatric urologists and nephrologists with a better understanding of the issues that must be addressed in using these newer surgical techniques and focus attention on the specific indications and contraindications for incorporating intestinal segments into the urinary tract. Although long-term follow-up information still remains sparse, it appears that regular surveillance programs are required and both pediatric nephrologists and urologists need to be part of these programs. 相似文献